{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:15:49Z","timestamp":1791296149125,"version":"4.1.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.semcancer.2018.08.001","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T17:04:19Z","timestamp":1533315859000},"page":"178-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis"],"prefix":"10.1016","volume":"53","author":[{"given":"Anahid","family":"Jewett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janko","family":"Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuman","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Wei","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2673-0998","authenticated-orcid":false,"given":"Tahmineh","family":"Safaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Peri\u0161i\u0107 Nanut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawaljit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.semcancer.2018.08.001_bib0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.stem.2007.08.001","article-title":"Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4","volume":"1","author":"Todaro","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"7123","key":"10.1016\/j.semcancer.2018.08.001_bib0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0015","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1038\/s41598-018-21478-8","article-title":"Oligomeric proanthocyanidins (OPCs) target cancer stem-like cells and suppress tumor organoid formation in colorectal cancer","volume":"8","author":"Toden","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2018.08.001_bib0020","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-17-3871","article-title":"Salivary gland cancer patient-derived xenografts enable characterization of cancer stem cells and new gene fusions associated with tumor progression","author":"Keysar","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.semcancer.2018.08.001_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011590","article-title":"Increased lysis of stem cells but not their differentiated cells by natural killer cells; de-differentiation or reprogramming activates NK cells","volume":"5","author":"Tseng","year":"2010","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-pathol-012615-044438","article-title":"Cancer stem cells: basic concepts and therapeutic implications","volume":"11","author":"Nassar","year":"2016","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.semcancer.2018.08.001_bib0035","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrc3368","article-title":"Cancer stem cell definitions and terminology: the devil is in the details","volume":"12","author":"Valent","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2018.08.001_bib0040","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrd4253","article-title":"Tackling the cancer stem cells \u2014 what challenges do they pose?","volume":"13","author":"Pattabiraman","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.semcancer.2018.08.001_bib0045","doi-asserted-by":"crossref","first-page":"T285","DOI":"10.1530\/ERC-14-0002","article-title":"Cancer stem-like cells and thyroid cancer","volume":"21","author":"Guo","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2018.08.001_bib0050","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1073\/pnas.0610117104","article-title":"Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma","volume":"104","author":"Prince","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0055","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.18632\/oncotarget.13644","article-title":"Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.semcancer.2018.08.001_bib0060","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7150\/jca.15989","article-title":"Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells\/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs","volume":"8","author":"Kozlowska","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.semcancer.2018.08.001_bib0065","series-title":"The Tumor Immunoenvironment","first-page":"361","article-title":"Tumor microenvironment may shape the function and phenotype of NK cells through the induction of split anergy and generation of regulatory NK cells","author":"Jewett","year":"2013"},{"key":"10.1016\/j.semcancer.2018.08.001_bib0070","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fimmu.2014.00269","article-title":"Induction of split anergy conditions natural killer cells to promote differentiation of stem cells through cell\u2013cell contact and secreted factors","volume":"5","author":"Tseng","year":"2014","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.semcancer.2018.08.001_bib0075","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00262-016-1866-x","article-title":"Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-\u03b3 after differentiation of glioblastoma by human natural killer cells","volume":"65","author":"Kozlowska","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"issue":"9","key":"10.1016\/j.semcancer.2018.08.001_bib0080","doi-asserted-by":"crossref","first-page":"866","DOI":"10.7150\/jca.11527","article-title":"Differential targeting of stem cells and differentiated glioblastomas by NK cells","volume":"6","author":"Tseng","year":"2015","journal-title":"J. Cancer"},{"key":"10.1016\/j.semcancer.2018.08.001_bib0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7150\/jca.2.443","article-title":"Tumor induced inactivation of natural killer cell cytotoxic function; implication in growth, expansion and differentiation of cancer stem cells","volume":"2","author":"Jewett","year":"2011","journal-title":"J. Cancer"},{"key":"10.1016\/j.semcancer.2018.08.001_bib0090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fimmu.2015.00259","article-title":"Differential cytotoxicity but augmented IFN-gamma secretion by NK cells after interaction with monocytes from humans, and those from wild type and myeloid-specific COX-2 knockout mice","volume":"6","author":"Tseng","year":"2015","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2018.08.001_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090921","article-title":"Knock-down of CD44 regulates endothelial cell differentiation via NF\u03baB-mediated chemokine production","volume":"9","author":"Olofsson","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","article-title":"The biology and role of CD44 in cancer progression: therapeutic implications","volume":"11","author":"Chen","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13045-016-0307-9","article-title":"Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma","volume":"9","author":"Jayachandran","year":"2016","journal-title":"J. Hematol. & Oncol."},{"issue":"2","key":"10.1016\/j.semcancer.2018.08.001_bib0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.semcancer.2010.04.002","article-title":"Normal stem cells and cancer stem cells: similar and different","volume":"20","author":"Shackleton","year":"2010","journal-title":"Semin. Cancer Biol."},{"issue":"8","key":"10.1016\/j.semcancer.2018.08.001_bib0115","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/bjc.2017.54","article-title":"A unified model of the hierarchical and stochastic theories of gastric cancer","volume":"116","author":"Y","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2018.08.001_bib0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.201202014","article-title":"The evolving concept of cancer and metastasis stem cells","volume":"198","author":"Baccelli","year":"2012","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.semcancer.2018.08.001_bib0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.stem.2015.02.015","article-title":"The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?","volume":"16","author":"Plaks","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semcancer.2018.08.001_bib0130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.coi.2017.11.003","article-title":"Natural killer cell education in human health and disease","volume":"50","author":"Boudreau","year":"2018","journal-title":"Curr. Opin. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2018.08.001_bib0135","doi-asserted-by":"crossref","first-page":"e1426518","DOI":"10.1080\/2162402X.2018.1426518","article-title":"Super-charged NK cells inhibit growth and progression of stem-like\/poorly differentiated oral tumors in vivo in humanized BLT mice; effect on tumor differentiation and response to chemotherapeutic drugs","volume":"7","author":"Kaur","year":"2018","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/j.semcancer.2018.08.001_bib0140","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.18632\/oncotarget.3250","article-title":"Split anergized Natural Killer cells halt inflammation by inducing stem cell differentiation, resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion","volume":"6","author":"Tseng","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.semcancer.2018.08.001_bib0145","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00262-016-1822-9","article-title":"Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice","volume":"65","author":"Kozlowska","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.semcancer.2018.08.001_bib0150","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2741\/4489","article-title":"Novel strategies to target cancer stem cells by NK cells; studies in humanized mice","volume":"22","author":"Kozlowska","year":"2017","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.semcancer.2018.08.001_bib0155","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fimmu.2017.00297","article-title":"Novel strategy to expand super-charged NK cells with significant potential to lyse and differentiate cancer stem cells: differences in NK expansion and function between healthy and cancer patients","volume":"8","author":"Kaur","year":"2017","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.semcancer.2018.08.001_bib0160","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1245\/s10434-007-9583-5","article-title":"Development and characterization of gemcitabine-resistant pancreatic tumor cells","volume":"14","author":"Shah","year":"2007","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2017.10.018","article-title":"Diagnostic and Prognostic Biomarkers in ovarian cancer and the potential roles of cancer stem cells - an updated review","volume":"362","author":"Muinao","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"6","key":"10.1016\/j.semcancer.2018.08.001_bib0170","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1158\/1078-0432.CCR-15-2157","article-title":"Characterization of biomarkers of tumorigenic and chemoresistant cancer stem cells in human gastric carcinoma","volume":"23","author":"Nguyen","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2018.08.001_bib0175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1091\/mbc.e10-04-0335","article-title":"The proliferation rate paradox in antimitotic chemotherapy","volume":"23","author":"Mitchison","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.semcancer.2018.08.001_bib0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.smim.2017.07.009","article-title":"NK cell-based immunotherapy for cancer","volume":"31","author":"Fang","year":"2017","journal-title":"Semin. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2018.08.001_bib0190","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","article-title":"The broad spectrum of human natural killer cell diversity","volume":"47","author":"Freud","year":"2017","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.semcancer.2018.08.001_bib0195","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccell.2017.06.009","article-title":"Control of metastasis by NK cells","volume":"32","author":"Lopez-Soto","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0200","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7150\/jca.5049","article-title":"Clinical relevance of natural killer cells following hematopoietic stem cell transplantation","volume":"4","author":"Palmer","year":"2013","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2018.08.001_bib0205","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.cdd.4402170","article-title":"NK cells at the interface between innate and adaptive immunity","volume":"15","author":"Moretta","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.semcancer.2018.08.001_bib0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu. Rev. Immunol."},{"issue":"26","key":"10.1016\/j.semcancer.2018.08.001_bib0215","doi-asserted-by":"crossref","first-page":"22310","DOI":"10.18632\/oncotarget.4208","article-title":"Regulation of split anergy in natural killer cells by inhibition of cathepsins C and H and cystatin F","volume":"6","author":"Magister","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0220","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7150\/jca.5519","article-title":"Dual functions of natural killer cells in selection and differentiation of stem cells; role in regulation of inflammation and regeneration of tissues","volume":"4","author":"Jewett","year":"2013","journal-title":"J. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2018.08.001_bib0225","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4049\/jimmunol.156.3.907","article-title":"Target-induced inactivation and cell death by apoptosis in a subset of human NK cells","volume":"156","author":"Jewett","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2018.08.001_bib0230","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fimmu.2017.00369","article-title":"Regulation of the functions of natural cytotoxicity receptors by interactions with diverse ligands and alterations in splice variant expression","volume":"8","author":"Pazina","year":"2017","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.semcancer.2018.08.001_bib0235","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.4049\/jimmunol.1500447","article-title":"NK cells preferentially target tumor cells with a cancer stem cell phenotype","volume":"195","author":"Ames","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2018.08.001_bib0240","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3389\/fimmu.2017.00870","article-title":"Efficient killing of murine pluripotent stem cells by natural killer (NK) cells requires activation by cytokines and partly depends on the activating NK receptor NKG2D","volume":"8","author":"Groschel","year":"2017","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.semcancer.2018.08.001_bib0245","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","article-title":"Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation","volume":"107","author":"Spaggiari","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2018.08.001_bib0250","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2018.08.001_bib0255","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3389\/fimmu.2015.00576","article-title":"Augmented IFN-gamma and TNF-alpha induced by probiotic Bacteria in NK cells mediate differentiation of stem-like tumors leading to inhibition of tumor growth and reduction in inflammatory cytokine release; regulation by IL-10","volume":"6","author":"Bui","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2018.08.001_bib0260","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2016.00262","article-title":"Human circulating and tissue-resident CD56(bright) natural killer cell populations","volume":"7","author":"Melsen","year":"2016","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.semcancer.2018.08.001_bib0265","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1073\/pnas.1012356108","article-title":"Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16(+) NK cells as rapid producers of abundant IFN-\u03b3 on activation","volume":"108","author":"De Maria","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7 Pt 1","key":"10.1016\/j.semcancer.2018.08.001_bib0270","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1158\/1078-0432.CCR-05-2306","article-title":"Coengagement of CD16 and CD94 receptors mediates secretion of chemokines and induces apoptotic death of naive natural killer cells","volume":"12","author":"Jewett","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.semcancer.2018.08.001_bib0275","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/1547691X.2013.877104","article-title":"Natural killer cells as effectors of selection and differentiation of stem cells: role in resolution of inflammation","volume":"11","author":"Jewett","year":"2014","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.semcancer.2018.08.001_bib0280","first-page":"6","article-title":"Endothelial cells express NKG2D ligands and desensitize antitumor NK responses","author":"Thompson","year":"2017","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.semcancer.2018.08.001_bib0285","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1393597","article-title":"Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15","volume":"7","author":"Ochoa","year":"2018","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0290","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00262-013-1501-z","article-title":"Cellular and molecular pathways in the tumor immunoenvironment: 3rd cancer immunotherapy and Immunomonitoring (CITIM) meeting, 22\u201325 April 2013, Krakow, Poland","volume":"63","author":"Shurin","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"issue":"8","key":"10.1016\/j.semcancer.2018.08.001_bib0295","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nri2604","article-title":"Oncogenic stress sensed by the immune system: role of natural killer cell receptors","volume":"9","author":"Raulet","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"24","key":"10.1016\/j.semcancer.2018.08.001_bib0300","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.4755","article-title":"Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: role in osteoclast-mediated NK cell activation","volume":"6","author":"Tseng","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.semcancer.2018.08.001_bib0305","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-08-3712","article-title":"Expansion of highly cytotoxic human natural killer cells for cancer cell therapy","volume":"69","author":"Fujisaki","year":"2009","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2018.08.001_bib0310","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/14653240902807034","article-title":"Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells","volume":"11","author":"Berg","year":"2009","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0315","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2004-12-4797","article-title":"Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells","volume":"106","author":"Imai","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.semcancer.2018.08.001_bib0320","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.it.2010.06.003","article-title":"New views on natural killer cell-based immunotherapy for melanoma treatment","volume":"31","author":"Burke","year":"2010","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2018.08.001_bib0325","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12032-007-0007-y","article-title":"Clinical stage-depending decrease of NK cell activity in multiple myeloma patients","volume":"24","author":"Jurisic","year":"2007","journal-title":"Med. Oncol."},{"issue":"9244","key":"10.1016\/j.semcancer.2018.08.001_bib0330","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(00)03231-1","article-title":"Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population","volume":"356","author":"Imai","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.semcancer.2018.08.001_bib0335","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1178421","article-title":"Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients","volume":"5","author":"Bucklein","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcancer.2018.08.001_bib0340","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3389\/fimmu.2018.01229","article-title":"Deficiencies in natural killer cell numbers, expansion, and function at the pre-neoplastic stage of pancreatic cancer by KRAS mutation in the pancreas of obese mice","volume":"9","author":"Kaur","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.semcancer.2018.08.001_bib0345","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00262-007-0437-6","article-title":"Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab\u2019)2 fragment of anti-CD16 antibody","volume":"57","author":"Jewett","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"issue":"10","key":"10.1016\/j.semcancer.2018.08.001_bib0350","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.4049\/jimmunol.159.10.4815","article-title":"Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells","volume":"159","author":"Jewett","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2018.08.001_bib0355","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-17-1846","article-title":"T cell exhaustion signatures vary with tumor type and are severe in glioblastoma","author":"Woroniecka","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2018.08.001_bib0360","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1146\/annurev.immunol.21.120601.141110","article-title":"T cell anergy","volume":"21","author":"Schwartz","year":"2003","journal-title":"Annu. Rev. Immunol."},{"issue":"4-5","key":"10.1016\/j.semcancer.2018.08.001_bib0365","first-page":"194","article-title":"Natural killer cell subsets: maturation, differentiation and regulation","volume":"12","author":"Bonavida","year":"1993","journal-title":"Nat. Immun."},{"key":"10.1016\/j.semcancer.2018.08.001_bib0370","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.coi.2018.03.022","article-title":"Natural killer cells target and differentiate cancer stem-like cells\/undifferentiated tumors: strategies to optimize their growth and expansion for effective cancer immunotherapy","volume":"51","author":"Kaur","year":"2018","journal-title":"Curr. Opin. Immunol."},{"issue":"7","key":"10.1016\/j.semcancer.2018.08.001_bib0375","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1084\/jem.192.7.1059","article-title":"DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells","volume":"192","author":"Wu","year":"2000","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.semcancer.2018.08.001_bib0380","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1182\/blood-2012-02-408732","article-title":"Impaired natural killer cell self-education and \u201cmissing-self\u201d responses in Ly49-deficient mice","volume":"120","author":"Belanger","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2018.08.001_bib0385","doi-asserted-by":"crossref","first-page":"e2301","DOI":"10.1038\/cddis.2016.212","article-title":"WASH has a critical role in NK cell cytotoxicity through Lck-mediated phosphorylation","volume":"7","author":"Huang","year":"2016","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.semcancer.2018.08.001_bib0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044244","article-title":"SHP-1 phosphatase is a critical regulator in preventing natural killer cell self-killing","volume":"7","author":"Mahmood","year":"2012","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.semcancer.2018.08.001_bib0395","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1116674","article-title":"The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells","volume":"5","author":"Textor","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcancer.2018.08.001_bib0400","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3389\/fimmu.2017.01606","article-title":"Suppression of gingival NK cells in precancerous and cancerous stages of pancreatic cancer in KC and BLT-Humanized mice","volume":"8","author":"Kaur","year":"2017","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.semcancer.2018.08.001_bib0405","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1016\/j.lfs.2005.10.015","article-title":"Interleukin-6 decreases senescence and increases telomerase activity in malignant human cholangiocytes","volume":"78","author":"Yamagiwa","year":"2006","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.semcancer.2018.08.001_bib0410","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3892\/ol.2011.279","article-title":"A review of the anti-tumor effect of the combined administration of a cyclooxygenase-2 selective inhibitor and a non-specific immunostimulant protein-bound polysaccharide on an advanced colon cancer model using colon cancer cell lines","volume":"2","author":"Katsumata","year":"2011","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0415","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.smim.2014.01.008","article-title":"The two faces of IL-6 in the tumor microenvironment","volume":"26","author":"Fisher","year":"2014","journal-title":"Semin. Immunol."},{"issue":"2","key":"10.1016\/j.semcancer.2018.08.001_bib0420","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.it.2014.12.008","article-title":"Versatile functions for IL-6 in metabolism and cancer","volume":"36","author":"Mauer","year":"2015","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.semcancer.2018.08.001_bib0425","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/abbs\/gmw002","article-title":"Leukocyte populations and IL-6 in the tumor microenvironment of an orthotopic colorectal cancer model","volume":"48","author":"Miller","year":"2016","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.semcancer.2018.08.001_bib0430","first-page":"616","article-title":"Cysteine cathepsins as regulators of the cytotoxicity of NK and T cells","volume":"5","author":"Perisic Nanut","year":"2014","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.semcancer.2018.08.001_bib0435","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1073\/pnas.96.15.8627","article-title":"Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo","volume":"96","author":"Pham","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0440","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7150\/jca.5044","article-title":"Cystatins in immune system","volume":"4","author":"Magister","year":"2013","journal-title":"J. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2018.08.001_bib0445","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/sj.emboj.7601979","article-title":"Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysis","volume":"27","author":"Hamilton","year":"2008","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.semcancer.2018.08.001_bib0450","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0854.2009.00881.x","article-title":"Glycosylation directs targeting and activation of cystatin f from intracellular and extracellular sources","volume":"10","author":"Colbert","year":"2009","journal-title":"Traffic"},{"key":"10.1016\/j.semcancer.2018.08.001_bib0455","article-title":"Cystatin F affects natural killer cell cytotoxicity","author":"Perisic Nanut","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0460","first-page":"151","article-title":"CMAP: a novel cystatin-like gene involved in liver metastasis","volume":"59","author":"Morita","year":"1999","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.semcancer.2018.08.001_bib0465","first-page":"2591","article-title":"Cystatin-like metastasis-associated protein mRNA expression in human colorectal cancer is associated with both liver metastasis and patient survival","volume":"8","author":"Utsunomiya","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2018.08.001_bib0470","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2407-10-17","article-title":"Cystatin E\/M suppresses legumain activity and invasion of human melanoma","volume":"10","author":"Briggs","year":"2010","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.semcancer.2018.08.001_bib0475","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1250051","article-title":"Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma","volume":"5","author":"Leivas","year":"2016","journal-title":"Oncoimmunology"},{"issue":"24","key":"10.1016\/j.semcancer.2018.08.001_bib0480","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1158\/0008-5472.CAN-13-3583","article-title":"Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment","volume":"74","author":"Cekic","year":"2014","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.semcancer.2018.08.001_bib0485","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1089\/thy.2012.0560","article-title":"CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer","volume":"23","author":"Gogali","year":"2013","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.semcancer.2018.08.001_bib0490","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1392426","article-title":"Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors","volume":"7","author":"Lopez-Cobo","year":"2018","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0495","first-page":"173","article-title":"Impaired zeta chain expression and IFN-gamma production in peripheral blood T and NK cells of patients with advanced lung cancer","volume":"21","author":"Ciszak","year":"2009","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.semcancer.2018.08.001_bib0500","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005926","article-title":"Serum interleukin-6 is associated with pancreatic ductal adenocarcinoma progression pattern","volume":"96","author":"Kim","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.semcancer.2018.08.001_bib0505","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1158\/1535-7163.MCT-16-0899","article-title":"IL6 receptor blockade enhances chemotherapy efficacy in pancreatic ductal adenocarcinoma","volume":"16","author":"Long","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"40","key":"10.1016\/j.semcancer.2018.08.001_bib0510","doi-asserted-by":"crossref","first-page":"65982","DOI":"10.18632\/oncotarget.11786","article-title":"Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells","volume":"7","author":"Nagathihalli","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.semcancer.2018.08.001_bib0515","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/ijc.29445","article-title":"Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer","volume":"137","author":"Goumas","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2018.08.001_bib0520","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ccr.2011.03.009","article-title":"Stat3\/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer","volume":"19","author":"Lesina","year":"2011","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.semcancer.2018.08.001_bib0525","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00262-013-1466-y","article-title":"Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFbeta1","volume":"62","author":"Xu","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"issue":"9","key":"10.1016\/j.semcancer.2018.08.001_bib0530","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s00262-005-0093-7","article-title":"Inhibition of nuclear factor kappa B (NFkappaB) activity in oral tumor cells prevents depletion of NK cells and increases their functional activation","volume":"55","author":"Jewett","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V74.1.1.1","article-title":"The biology of interleukin-6","volume":"74","author":"Kishimoto","year":"1989","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.semcancer.2018.08.001_bib0540","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2174\/1566524011313040012","article-title":"Understanding and targeting osteoclastic activity in prostate cancer bone metastases","volume":"13","author":"Sottnik","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.semcancer.2018.08.001_bib0545","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.coi.2018.03.008","article-title":"Oncolytic viruses and immunity","volume":"51","author":"Chaurasiya","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.semcancer.2018.08.001_bib0550","doi-asserted-by":"crossref","first-page":"14004","DOI":"10.1038\/mto.2014.4","article-title":"Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer","volume":"1","author":"Zamarin","year":"2014","journal-title":"Mol. Ther. Oncolytics"},{"issue":"4","key":"10.1016\/j.semcancer.2018.08.001_bib0555","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI98047","article-title":"PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy","volume":"128","author":"Zamarin","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"226","key":"10.1016\/j.semcancer.2018.08.001_bib0560","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008095","article-title":"Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy","volume":"6","author":"Zamarin","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.semcancer.2018.08.001_bib0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.08.027","article-title":"Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy","volume":"170","author":"Ribas","year":"2017","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.semcancer.2018.08.001_bib0570","doi-asserted-by":"crossref","first-page":"8108","DOI":"10.1128\/JVI.00211-09","article-title":"Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase","volume":"83","author":"Jarahian","year":"2009","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.semcancer.2018.08.001_bib0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066825","article-title":"Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo","volume":"8","author":"Ogbomo","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.semcancer.2018.08.001_bib0580","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/ijc.25415","article-title":"Enhancement of NK cell antitumor responses using an oncolytic parvovirus","volume":"128","author":"Bhat","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.semcancer.2018.08.001_bib0585","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1158\/0008-5472.CAN-06-3974","article-title":"Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus","volume":"67","author":"Diaz","year":"2007","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0590","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1158\/0008-5472.CAN-12-1993","article-title":"Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells","volume":"73","author":"Tai","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2018.08.001_bib0595","first-page":"35","article-title":"Oncolytic viral therapy for pancreatic cancer: current research and future directions","volume":"3","author":"Ady","year":"2014","journal-title":"Oncolytic Virother."},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0600","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jso.24626","article-title":"Oncolytic viral therapy for pancreatic cancer","volume":"116","author":"Ahmad","year":"2017","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2018.08.001_bib0605","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jso.24626","article-title":"Oncolytic viral therapy for pancreatic cancer","volume":"116","author":"Rahal","year":"2017","journal-title":"J. Surg. Oncol."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X18300488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X18300488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T04:42:12Z","timestamp":1693802532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X18300488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":121,"alternative-id":["S1044579X18300488"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2018.08.001","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2018.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}